KIDS - NASDAQ
OrthoPediatrics Corp.
$16.92
+0.65%OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
At a Glance
Live SnapshotOrthoPediatrics Corp. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
OrthoPediatrics Corp. Income Statement
KIDS • NASDAQ
| OrthoPediatrics Corp. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
236.3M | 204.7M | 148.7M | 122.3M | 98M | 71.1M | 72.6M | 57.6M | 45.6M | 37.3M | 31M | 23.7M | |
GROSS PROFIT | ||||||||||||
(63.7M) | (56.1M) | (37.5M) | (31.6M) | (24.6M) | (16M) | (17.9M) | (14.9M) | (11.2M) | (10.9M) | (9.4M) | (7.1M) | |
172.7M | 148.6M | 111.3M | 90.7M | 73.4M | 55M | 54.6M | 42.7M | 34.5M | 26.4M | 21.6M | 16.6M | |
OPERATING INCOME | ||||||||||||
(201.7M) | (178.1M) | (138M) | (116.1M) | (91.4M) | (81.8M) | (63.7M) | (52.2M) | (40.9M) | (32.5M) | (28.2M) | (23.7M) | |
(192.6M) | (167.1M) | (126.1M) | (104M) | (85.7M) | (70.2M) | (57.9M) | (47.5M) | (37.5M) | (30.3M) | (26.4M) | (22.1M) | |
(9.1M) | (11M) | (10.9M) | (8.5M) | (5.5M) | (5.3M) | (5.7M) | (4.7M) | (3.4M) | (2.2M) | (1.8M) | (1.7M) | |
-29M | -29.5M | -26.8M | -25.4M | -18M | -26.8M | -9.1M | -9.6M | -6.5M | -6.1M | -6.6M | -7.1M | |
PRE-TAX INCOME | ||||||||||||
(6M) | (2.6M) | (0.0) | (2.4M) | (2.2M) | (3.4M) | (3.5M) | (2.3M) | (2.5M) | (1.5M) | (1.2M) | (2.5M) | |
-6M | -2.6M | 198K | -2.4M | -2.2M | -3.4M | -3.5M | -2.3M | -2.5M | -1.5M | -1.2M | -2.5M | |
(0.0) | (0.0) | (985K) | (3.6M) | (150K) | (6.3M) | (0.0) | -217K | (30K) | (0.0) | -31K | -67K | |
-10.2M | -12.4M | 5.4M | 21.7M | 636K | -6.9M | -3.6M | -2.5M | -2.5M | -445K | -1.3M | -2.6M | |
-39.2M | -41.9M | -21.3M | -3.7M | -17.4M | -33.7M | -12.7M | -12M | -8.9M | -6.6M | -7.9M | -9.8M | |
NET INCOME | ||||||||||||
(460K) | -4.1M | -338K | -4.9M | -1.1M | -723K | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-39.6M | -37.8M | -21M | 1.3M | -16.3M | -32.9M | -13.7M | -12M | -8.9M | -6.6M | -7.9M | -9.5M |
SEC Filings
KIDS - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 01, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 20, 2026 | April 20, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 01, 2026 | March 31, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 04, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 12, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 12, 2026 | 2026 |
Related Guides
Continue your KIDS research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.